Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Biofilm Producing Methicillin-Resistant Staphylococcus aureus (MRSA) Infections in Humans: Clinical Implications and Management
Article in Pathogens (January 2024)
Updates on Staphylococcal Vaccines
Article in Microbiology Research (December 2023)